Image
Back to top
Prof Brian Kirby
Consultant Dermatologist
Professor Brian Kirby is Consultant Dermatologist at St Vincent’s University Hospital, Dublin, Ireland, and Full Clinical Professor at University College Dublin, Ireland.
Professor Kirby’s clinical and research interests include psoriasis and hidradenitis suppurativa. He is co-Chair of the Dublin Hidradenitis Suppurativa Research Group and a Principal Investigator at the Charles Institute of Dermatology at University College Dublin.
Professor Kirby is also a former member of the steering committee of British Association of Dermatologists Biologics and Immunomodulatory Register (BADBIR), a member of the International Psoriasis Council (IPC), a member of the scientific committee of the European Hidradenitis Suppurativa Foundation (EHSF) and Chairperson of the Clinical Advisory Group of Dermatology at the Royal College of Physicians of Ireland.
He has authored or co-authored more than 250 publications, the majority of which are on psoriasis and hidradenitis suppurativa. Additionally, he is Associate Editor of the British Journal of Dermatology and Dermatology.
0 resources
File
As HS is unique to every patient, their conversation should be too. Prompt your patients to download/print out this guide to take to future appointments
EU-DA-2300366
File
Many people with HS encounter a variety of medical experts from different specialties. Introduce your patients to the people they may meet along the way
EU-DA-2400242
File
Help your patients separate fact from fiction with this myth-busting guide to what HS really is and isn't
EU-DA-2400243
File
Here, patients can find everything they need to know about HS, from common triggers and management options to the types of specialists involved in HS care
EU-DC-2400043
File
Intended for general practitioners who are referring patients with HS to dermatologists when mild-to-moderate HS has not responded to first-line treatment
EU-DC-2400044
File
This template is intended for general practitioners looking to refer patients with suspected or severe HS to dermatologists in secondary care
EU-DC-2400044